Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q4 EPS of ($0.39), $0.03 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $4.37 million versus the consensus estimate of $4.5 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.